Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Two key brain functions may improve during aging

It's long been believed that advancing age leads to broad declines in our mental abilities. Now new research from Georgetown University Medical Center offers surprisingly good news by countering this view.

19 Aug 2021

People with cognitively stimulating jobs have lower risk of dementia in old age, study finds

People with mentally stimulating jobs have a lower risk of dementia in old age than those with non-stimulating jobs, finds a study published by The BMJ today.

19 Aug 2021

Scientists identify the main components driving amyloid beta-associated synapse degeneration

Healthy adult brains are endowed with a vast number of synapses, structures that relay signals across nerve cells to enable communications, information processing and storage throughout the nervous system.

18 Aug 2021

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Immigrants to Canada have a 33% lower rate of stroke than long-term residents, according to a study published in the August 18, 2021, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Aug 2021

Practicing meditation for just a couple of months can make your brain quicker

Just eight weeks of meditation studies can make your brain quicker, according to new research from Binghamton University, State University of New York.

18 Aug 2021

Scientists could elucidate how and why gut microbes contribute to cognitive impairment

Recent research has found that changes in the gut microbiota - the trillions of bacteria and other microbes that live in the intestines - can alter the brain and behavior. Now, a study led by scientists at UCLA could elucidate how and why that phenomenon occurs.

17 Aug 2021

Protein implicated in tumor growth may protect against neurodegenerative diseases

Cells translate their genetic material at rapid rates with exquisite precision to reproduce, repair damage or even combat disease.

17 Aug 2021

Research reveals link between widespread pain and heightened risk of dementia, stroke

Widespread pain is linked to a heightened risk of all types of dementia, including Alzheimer's disease, and stroke finds research.

17 Aug 2021

Brain diseases could have a greater societal impact than Covid-19, research finds

New research has found that brain diseases, such as Parkinson’s and Alzheimer’s, are surfacing earlier, proving more fatal, and could have a greater societal impact than Covid-19.

17 Aug 2021

Having a good listener is associated with greater cognitive resilience

Supportive social interactions in adulthood are important for your ability to stave off cognitive decline despite brain aging or neuropathological changes such as those present in Alzheimer's disease, a new study finds.

16 Aug 2021

Study illuminates the link between cholesterol and Alzheimer's-associated toxic protein clumps

A team co-led by scientists at Scripps Research has used advanced imaging methods to reveal how the production of the Alzheimer's-associated protein amyloid beta (Aβ) in the brain is tightly regulated by cholesterol.

13 Aug 2021

Scientists find clues to how a specific synapse type regulates anxiety-like behavior

The mechanisms behind the organization of neuronal synapses remain unclear owing to the sheer number of genes, proteins, and neuron types involved.

12 Aug 2021

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.

12 Aug 2021

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Ultra-sensitive Simoa® HD-X technology powers new findings that detect rapid reduction of plasma P-tau217 from donanemab, Lilly’s investigational antibody therapy for Alzheimer's disease at 12 weeks

From Quanterix 9 Aug 2021

Light therapy may speed up the healing of burns by activating growth protein

Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study.

6 Aug 2021

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

The recent US Food and Drug Administration (FDA) approval of aducanumab – which has the potential to treat Alzheimer's disease – may provide a proof of concept that can be rapidly improved upon, writes Dennis Selkoe in this Perspective.

6 Aug 2021

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.

6 Aug 2021

Alzheimer's Disease News and Research

Further Reading

Two key brain functions may improve during aging

People with cognitively stimulating jobs have lower risk of dementia in old age, study finds

Scientists identify the main components driving amyloid beta-associated synapse degeneration

Study finds a lower rate of stroke among immigrants to Canada than long-term residents

Practicing meditation for just a couple of months can make your brain quicker

Scientists could elucidate how and why gut microbes contribute to cognitive impairment

Protein implicated in tumor growth may protect against neurodegenerative diseases

Research reveals link between widespread pain and heightened risk of dementia, stroke

Brain diseases could have a greater societal impact than Covid-19, research finds

Having a good listener is associated with greater cognitive resilience

Study illuminates the link between cholesterol and Alzheimer's-associated toxic protein clumps

Scientists find clues to how a specific synapse type regulates anxiety-like behavior

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Light therapy may speed up the healing of burns by activating growth protein

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Study reveals structural differences and unique polymorphs in amyloid-β fibrils

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News